| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Kaiser Permanente
| Professional | $1,202.26 | $1,202.26 | $1,202.26 | |
United
| Professional | $562.34 | $562.34 | $1,318.26 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the COVID-19 public health emergency
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Kaiser Permanente
| Professional | $1,202.26 | $1,202.26 | $1,202.26 | |
United
| Professional | $562.34 | $562.34 | $1,318.26 |